Hiroki Osumi

researcher

Hiroki Osumi is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-4742-0446

P106occupationresearcherQ1650915

Reverse relations

author (P50)
Q40074608A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication
Q96429221Circulating Tumor DNA as a Novel Biomarker Optimizing Chemotherapy for Colorectal Cancer
Q91424068Clinical impact of Epstein-Barr virus status on the incidence of lymph node metastasis in early gastric cancer
Q64938836Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer.
Q61455455Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer
Q57453268Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer
Q64066848Clinical utility of circulating tumor DNA for colorectal cancer
Q93362720Correction to: Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer
Q104515291Early hypertension and neutropenia are predictors of treatment efficacy in metastatic colorectal cancer patients administered FOLFIRI and vascular endothelial growth factor inhibitors as second-line chemotherapy
Q92961241Non-V600E BRAF mutations and EGFR signaling pathway in colorectal cancer
Q89122613Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer

Search more.